Leihong Xiang

机构：Fudan University, Huashan Hospital · ORCID：0000-0002-2712-3962

发表论文 101 篇 · 总被引 1866 次 · h-index 19

代表论文

• Oral tofacitinib, baricitinib and upadacitinib monotherapy for steroid‐resistant vitiligo: A prospective case series (2024 · Journal of the European Academy of Dermatology and Venereology · 被引 25)
• A prospective observational study of oral abrocitinib and narrow-band ultraviolet-B in refractory progressive vitiligo (2024 · Journal of the American Academy of Dermatology · 被引 16)
• The multifaceted role of autophagy in skin autoimmune disorders: a guardian or culprit? (2024 · Frontiers in Immunology · 被引 14)
• Global consensus on the management of melanin hyperpigmentation disorders (2025 · Journal of the European Academy of Dermatology and Venereology · 被引 10)
• Emerging role of regulatory T cells in the immunopathogenesis of vitiligo and implications for treatment (2024 · British Journal of Dermatology · 被引 9)
• Effectiveness and safety of ruxolitinib cream in Chinese patients with nonsegmental vitiligo (2025 · Journal of the American Academy of Dermatology · 被引 7)